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Abstract  Pneumonia  remains  one  of  the  most  important  causes  of  mortality.  In  Portugal,  it  is
the first  cause  of  respiratory  death,  excluding  lung  cancer.  This  is  a  retrospective  cohort  study
designed  to  seek  for  explanations,  identifying  the  characteristics  of  patients  and  measure  the
impact of  each  one  of  them  on  the  risk  of  dying  from  pneumonia.  We  analyzed  demographic
and clinical  data  of  all  patients  (pts)  with  18  years  or  older  with  pneumonia  requiring  hospi-
talization  registered  on  the  national  health  service  registry  of  mainland  Portugal  over  2015.
A total  of  36366  patients  corresponding  to  40696  pneumonia  hospital  admissions  in  2015  were
analyzed. Most  of  the  patients  were  very  old  (median  age  80  years).  Hospital  mortality  for
pneumonia  was  higher  among  older  (30,3%  pts  >  75  years).  Pneumococcus  is  the  more  frequent
bacterial  isolate,  reaching  41.2%  of  the  isolates  of  total  pneumonia  cases.  The  frequency  of
pneumococcus  decreases  with  aging;  conversely,  gram-negative  bacteria  and  staphylococcus
increase.  Pneumococcus  is  more  frequently  identified  in  the  winter,  closely  related  to  influenza
outbreaks.  Gram-negative  bacteria  are  more  prevalent  during  the  summer  months.  Diabetes,
obesity,  COPD,  and  tobacco  smoking  are  not  associated  with  an  increased  risk  of  dying  from
pneumonia.  Patients  older  than  75  years;  living  in  a  senior  house;  or  with  chronic  renal  disease,
lung cancer,  metastatic  disease,  mobility  impairment,  cachexia,  dementia,  cerebrovascular  dis-
ease, and  ischemic  heart  disease  are  at  greater  risk  of  dying  from  pneumonia.  Comorbidities
contribute  decisively  to  the  risk  of  dying  from  pneumonia  in  the  hospital,  regardless  of  their
type or  origin.
© 2019  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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isease.  William  Osler1 in  the  nineteenth  century  made  mul-
iple  descriptions  of  its  different  forms  of  presentation  and
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heir  relationship  with  frail,  vulnerable,  and  elderly  people.1
espite  medical  science,  better  health-care  access,  spe-
ialized  units,  sophisticated  life-support  systems,  and  even
xtracorporeal  membrane  oxygenation  (ECMO),  year  after
ear,  pneumonia  mortality  rates  reach  30%  of  all  respiratory
auses  of  death  in  the  Organization  for  Economic  Coopera-
ion  and  Development  (OECD)  countries  report.2 According
o  the  last  OECD  report,  Portugal  had  one  of  the  highest
ates  of  pneumonia  mortality.2 The  figures  on  pneumonia
ccurrence  and  their  distribution  in  the  community  (CAP)
re  almost  impossible  to  determine  accurately.  Studying  hos-
ital  admissions  for  moderate  to  severe  pneumonias  has
een  one  way  to  understand  the  characteristics  and  the
mpact  of  this  disease,3,4 at  least  the  most  severe  cases.
n  Portugal,  pneumonia  is  certainly  one  of  the  main  causes
f  death,  representing  43.9%  of  all  respiratory  mortality,
xcluding  lung  cancer,5 in  2015.  This  study  was  designed  to
eek  explanations  for  these  observations.  We  intend  to  ana-
yze  occurrence  patterns,  the  distribution  and  the  clinical
haracteristics  of  the  patients  with  moderate  and  severe
neumonias  requiring  hospital  admission  to  identify  the
ain  determinants  of  their  morbimortality.
bjective
his  study  aims  to  evaluate  the  demographic  distribution
nd  clinical  patterns  associated  with  patients  with  pneumo-
ia  requiring  hospitalization  and  their  impact  on  mortality.
sing  all  pneumonia  cases  admitted  during  2015,  we  will
reate  a  risk  model  generating  outcome  estimates  on  the
isk  of  dying  for  each  individual  patient.
atients and  methods
his  is  a  joint  project  of  the  Portuguese  Society  of  Pul-
onology  and  the  Priority  Health  Program  for  Respiratory
iseases  of  the  Portuguese  General  Directorate  of  Health.
In  this  study,  we  retrospectively  analyzed  all  patients
equiring  hospitalization  for  pneumonia  in  the  National
ealth  Service  (NHS)  hospitals  in  mainland  Portugal  in  2015.
he  Central  Administration  of  the  Portuguese  Health  System
f  the  Ministry  of  Health  (ACSS)  keeps  administrative,  demo-
raphic,  and  clinical  data  of  all  admissions  of  NHS  hospitals
hat  cover  the  whole  Portuguese  resident  population.  The
ntirely  anonymized  patients’  data,  encoded  from  medical
ecords  by  specialized  codifiers,  using  the  International  Clas-
ification  of  Diseases,  Ninth  Revision  Clinical  Modification
ICD-9-CM),6 was  the  data  source  for  this  study.
To  make  the  study  more  patient-driven,  a  code  num-
er  from  each  patient  was  generated,  maintaining  absolute
nonymization,  allowing  us  identify  if  a  particular  database
ntry,  was  a  primary  case  or  a  readmission.  The  age,  gen-
er,  geographical  location  of  residence  and  hospital  where
he  admission  occurred,  date  of  hospitalization  up  to  the
rst  five  registered  diagnoses  by  hospital  admission,  proce-
ures,  etiologic  microbial  information,  previous  surgery  or
raumatic  event,  readmission  event,  time  of  readmission,
nd  outcome  were  the  primary  data  we  retrieved  from  the
atabase.  This  database  included  up  to  20  entries  for  diag-
osis  and  procedures.  We  decided  to  include  the  first  five
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egistered  diagnoses  because  the  majority  of  the  admissions
ad,  at  least,  five  entries  for  diagnosis.
To  make  diagnostic  information  usable,  we  developed
 decision  tree,  creating  diagnostic  groups  built  from  the
iagnostic  codes  of  the  ICD-9-CM  registered  at  each  hospi-
alization  (supplementary  material).  The  diagnostic  groups
ere  constructed  in  a  way  that  could  easily  be  clas-
ified  as  comorbidities  (diabetes,  chronic  renal  failure,
ementia,  cachexia,  cancer  metastatic  disease,  obesity,
lcohol/tobacco,  etc.)  or  complications  of  the  pneumonia
f  they  were  being  classified  as  consequences  of  the  dis-
ase  (sepsis,  respiratory  failure,  shock,  empyema,  acute
enal  failure,  acid-base  or  hydroelectrolytic  disturbances,
tc.).  After  this  classification  procedure  (supplementary
aterial),  the  patients’  characteristics  (age  group,  gender,
iabetes,  asthma,  COPD,  cerebrovascular-disease  sequels,
ementia,  mobility  impairment  of  any  cause,  cachexia,
schemic  heart  disease,  chronic  renal  failure,  cancer  of  any
ite,  metastatic  cancer,  lung  cancer,  tobacco  smoking,  obe-
ity,  living  in  a  senior  house,  length  of  patient  stay,  airway
spiration,  sepsis,  sepsis  and  shock)  and  microbiologic  data
ere  analyzed.
nclusion  criteria
atients  aged  18  years  or  older  admitted  to  hospital  with
 discharge  primary  diagnosis  of  pneumonia  (ICD-9-CM
80--486,  487.0)  or  patients  hospitalized  with  primary  diag-
osis  of  sepsis  (ICD-9-CM  038-0389)  if  the  diagnosis  of
neumonia  was,  at  least,  present  in  the  second  of  the  five
nalyzed  discharge  diagnosis,  were  included.
xclusion  criteria
atients  younger  than  18  years  old  or  hospitalized  with  a  dis-
harge  primary  diagnosis  other  than  pneumonia  or  a  primary
iagnosis  of  sepsis  and  other  than  pneumonia  in  the  second
iagnosis  were  excluded.
tatistical  analysis
he  clinical  and  demographic  variables  (see  Table  1)  were
ransformed  into  indicator  variables  and  coded  as0  if  the
haracteristic  was  absent  and  1if  present.  The  median  and
ge-group  intervals  presented  age.  The  generated  age-group
ariable  ‘‘age  75’’  was  dichotomous----1 if  the  patient  was  75
r  older  and  0  if  this  condition  was  not  met.  Clinical  variables
diabetes,  chronic  renal  disease,  shock,  COPD,  lung  cancer,
besity,  etc.)  were  coded  1  if  present  and  0  if  absent.  The
utcome  of  the  disease  was  coded  1  if  death  occurred  and
 if  otherwise  and  the  patient  recovered  from  the  disease.
he  interaction  of  all  these  variables  and  disease  outcome
as  expressed  as  odds  ratios  (ORs).  Some  of  them  were  also
isplayed  as  forest  plots.  A logistic  regression  was  created
o  adjust  the  influence  between  the  patient  characteristics
nd  the  outcome.7 The  individual  patient  outcome  estimates
ould  be  obtained  by  getting  the  sum  of  the  products  of
he  coefficient  of  each  independent  variable  (1-n)  included
n  the  logistic  model  (Fig.  2)  and  their  code  (X1-n)----1  if  a
articular  characteristic  was  present  and  0 if  absent----and
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Table  1  Patients  &  Characteristics  &  Case  Fatalities.
Median  Age  80  years  72.6  ±  22.4  (Mean  ±  STD)  Total  (pts/adm)  :  36.366/
40,696
Age  Groups  (years)  Cases  no (%)  Hospital  Mortality  no (%)
18--50 2,183  (6.0)  115  (5.3)
50--60 2,175  (6.0)  257  (11.8)
60--70 3,923  (10.8)  567  (14.5)
70--80 8,171  (22.5)  1,754  (21.5)
80--90 14,356  (39.)  4,291  (29.9)
> 90  5,558  (15.2)  2,140  (38.5)
Total 36,366  9,124  (25.1)
Characteristic  (code) Cases  by  Characteristic Fatality  by  Characteristic  no (%)
Age 75  (1/0) 25,077  (69.0)  /  11,298  (31.0) 7,608  (30.3)  /  1,516  (13.4)
Gender (Male,  1  /  Female,  2)  18,925  (52.0)  /  17,441  (48.0)  4,909  (25.9)  /  4,215  (24.2)
Readmission (1/0)  3,584  (9.9)  /  32,782  (90.1)  1,093  (30.5)  /  8,031  (24.5)
Diabetes (1/0)  5,892  (16.3)  /  30,283  (83.7)  1,198  (20.3)  /  7,901  (26.09)
Obesity (1/0)  912  (2.6)  /  34,562  (97.4)  81  (9.0)  /  8,915  (25.8)
Tobacco (1/0)  1,197  (3.3)  /  34,978  (96.7)  100  (8.4)  /  8,999  (25.7)
COPD (1/0)  4,337  (12.0)  /  31,838  (88.0)  773  (17.8)  /  8,326  (26.2)
Asthma (1/0)  727  (2.0)  /  35,448  (98.0)  49  (6.7)  /  9,050  (25.5)
Chronic Renal  Disease  (1/0)  4,106  (11.4)  /  32,069  (88.6)  1,150  (28.0)  /  7,949  (24.8)
Lung Cancer  (1/0)  607  (1.7)  /  35,568  (98.3)  244  (40.2)  /  8,855  (24.9)
Cancer (1,  yes  /  0,  no)  2,852  (7.8)  /  33,514  (92.2)  1,060  (37.2)  /  8,064  (24.0)
Metastatic Cancer  (1/0)  644  (1.8)  /  35,531  (98.2)  332  (51.6)  /  8,767  (24.7)
Ischemic Heart  Disease  (1/0)  1,732  (4.8)  /  34,443  (95.2)  499  (28.8)  /  8,600  (25.0)
Cachexia (1/0)  410  (1.1)  /  35,765  (98.9)  236  (57.6)  /  8,863  (24.8)
Dementia (1/0)  3,410  (9.4)  /  32,765  (90.6)  1,196  (35.1)  /  7,903  (24.1)
Mobility impairment  (1/0)  2,472  (6.8)  /  33,703  (93.2)  928  (37.5)  /  8,171  (24.2)
Senior House  living  (1/0)  925  (2.6)  /  35,246  (97.4)  379  (41.0)  /  8,720  (24.7)
Cerebrovascular  disease  (1/0)  2,388  (6.6)  /  33,787  (93.4)  754  (31.6)  /  8,345  (24.7)
Sepsis (1/0)  2,309  (6.4)  /  33,865  (93.6)  1,008  (43.7)  /  8,091  (23.9)
Sepsis and  Shock  (1/0) 400  (1.1)  /  35,775  (98.9)  224  (56.0)  /  8,875  (24.8)
Aspiration Pneumonia  (1/0) 132  (0.4)  /  36,234  (99.6) 81  (61.4)  /  9,043  (25.0)
Hospital Stay  ≤1  day/>  1  day  (1/0) 2,207  (6.0)  /  34,159  (94)  1,648  (74.7)  /  74.76  (21.9)
Comorbidities  (1/0) 30,565  (84.1)  /  5,801  (15.9) 7,892  (25.8)  /  1,232  (21.2)
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Coded 1 if the characteristic is present, 0 if absent; pts (patients)
replacing  this  in  the  formula  1/1+e-(Constant-
∑
(1X1+
2X2+.  . .  nXn))obtain  the  individual  probability  of  the  risk
of  dying  from  pneumonia  in  a  hospital.  We  used  STATA  Sta-
tistical  Data  Analysis  9.08 and  BiostatXL  MIX  2.0  (available
at:  http://www.meta-analysis-made-easy.com)  to  compute
all  these  estimates.9
Results
A  total  of  36,366  patients  corresponding  to  40,696  pneu-
monia  hospital  admissions  in  2015  (Table  1)  were  evaluable.
Hospital  mortality  (case-fatality)  was  higher  among  patients
with  multiple  admissions  (30.6%  vs.  24.5%).
Most  of  the  patients  were  hospitalized  from  1  to  15
days.  Most  of  the  patients  (see  Table1)  were  very  old,
18,655  (47.1%)  aged  80  or  older.  Hospital  mortality  increased
sharply  after  the  60  s,  reaching  38.5%  after  the  90  s.Most  of  the  patients  admitted  to  hospital  for  pneumonia
were  male  18,925  (52%).  Diabetes,  COPD,  and  chronic  renal
disease  (CRD)  were  present  in  5892  (16.3%),  4337  (12%),  and
4106  (11.4%)  of  the  patients,  respectively  (Table  1).  Cancer
d
m
p
 (admissions).
f  any  site  was  present  in  2852  (7.8%)  patients,  including
07  (1.7%)  with  lung  cancer  and  644  (1.8%)  with  metastatic
isease.  Cardiac  ischemic  disease  was  an  important  comor-
idity  identified  in  1732  (4.8%)  patients.  Dementia,  serious
obility  impairment,  cerebrovascular  disease,  cachexia,
nd  living  in  senior  housing  were  identified  in  3410  (9.4%),
472  (6.8%),  2388  (6.6%),  410  (1.1%),  and  925  (2.6%),  respec-
ively,  of  the  pneumonia  patients.
Only  in  3220  (8.9%)  of  the  pneumonia  admissions  was  it
ossible  to  establish  the  etiology  of  the  pneumonia  (sup-
lementary  material).  Pneumococcus  was  the  microbiologic
gent  most  frequently  identified.  Other  bacteria  such  as  mis-
ellaneous  gram-negative  and  multiresistant  Staphylococcus
ureus  were  also  relevant  isolates  identified  in  the  patients
ith  pneumonia  requiring  hospitalization.
Most  pneumonia  admissions  happened  during  the  colder
onths,  closely  related  to  peak  rates  of  influenza.  However,
he  highest  pneumonia  hospital  mortality  rates  occurred
uring  the  summer  from  July  to  September  (supplementary
aterial).
The  distribution  of  microbiological  isolates  showed  us  the
redominance  of  Pneumococcus  during  the  entire  year  (sup-
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Condition
Microbiology
Comorbidities
Complications
Aspiration (1/0)
low risk
low risk
high risk
high risk
Pneumococus (1/0)
Staphilococus (1/0)
MRSA (1/0)
Klebsiella (1/0)
Pseudomona spp (1/0)
E.coli (1/0)
Gram neg (1/0)
Sepsis (1/0)
Shock (1/0)
Respiratory (1/0)
Readmision (1/0)
Cardiac (1/0)
Gender (M/F)
Diabetes (1/0)
CRD (1/0)
Lung Cancer (1/0)
Metastatic (1/0)
Mobility (1/0)
Cachexia (1/0)
Demencia (1/0)
COPD (1/0)
CVD (1/0)
IHD (1/0)
0.10.1 11 1010
0.1 0.11 110 10
OR
OR
OR
Senior House (1/0)
Obesity (1/0)
Alcohol Tobacco (1/0)
Hospital stay (≤1/ >1)
2.81 (2.65; 2.99)
0.72 (0.68; 0.77)
1.18 (1.10; 1.27)
2.03 (1.72; 2.39)
3.25 (2.78; 3.80)
1.88 (1.72; 0.04)
4.12 (3.38; 5.01)
1.7 (1.58; 1.83)
0.61 (0.56; 0.66)
1.41 (1.29; 1.54)
1.22 (1.09; 1.35)
4.78 (3.36; 6.78)
2.47 (2.26; 2.69)
4.41 (3.78; 5.13)
0.67 (0.62; 0.72)
0.99 (0.94; 1.04)
1.63 (1.51; 1.75)0.93 (0.76; 1.13)
0.69 (0.53; 0.91)
1.59 (1.10; 2.30)
1.04 (0.77; 1.41)
2.21 (1.84; 2.66)
1.15 (0.86; 1.54)
0.41 (0.35; 0.48)
1.1 (1.05; 1.15)
2.11 (1.85; 2.41)
0.28 (0.22; 0.35)
0.26 (0.10; 0.32)
10.52 (9.53; 11.62)
Age ≥ 75/<75
OR (CI)
OR (CI)
OR (CI)
OR (CI)
Fig.  1  Pneumonia  Hospital  Mortality  --  Sub-group  analysis.
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OR (odds  ratio),  CRD  (chronic  renal  disease),  CVD  (cerebrovas
taphylococcus  aureus),  E.  coli  (Escherichia  coli);  hospital  ≤1/
lementary  material),  representing  more  than  40%  of  all
irus  and  bacteria  identifications.  The  microbiologic  identi-
cations  had  different  distributions  throughout  the  months
f  the  year  (supplementary  material).  There  is  a  propor-
ional  increase  of  the  identification  rate  of  Staphylococcus
nd  gram-negative  bacteria  species,  from  July  to  Septem-
er  (supplementary  material).  During  winter  (December,
anuary,  and  February),  most  bacteria  isolates  were  Pneu-
ococcus.  The  microbiology  seemed  to  be  related  to  the
ge  of  the  patients  (supplementary  material).  Pneumococ-
us  and  atypical  bacteria  were  more  frequently  identified
n  younger  age  groups.  Conversely,  among  the  elderly,
part  from  Pneumococcus,  Staphylococcus,  including  mul-
iresistant  Staphylococcus  aureus  (MRSA)  and  miscellaneous
ram-bacteria  (supplementary  material),  plays  the  most
mportant  role.  There  is  a  clear  downward  trend  of  the
requency  of  pneumococcal  isolates  from  the  50  s  (sup-
lementary  material).  The  atypical  bacteria  were  most
requently  identified  in  the  18--50  age  group,  decreasing
rom  there  on.  Older  age  groups  were  more  prone  to  get
neumonia  caused  by  gram-negative  and  Staphylococcus
acteria  and  be  admitted  to  the  hospital.
t
o
r  disease),  IHD  (ischemic  heart  disease),  MRSA  (multiresistant
ays  of  hospital  stay)]
From  all  patients’  characteristics,  we  selected  the  most
requent  to  evaluate  their  impact  on  pneumonia  hospital
ortality.  These  characteristics  were  classified  into  four
roups:  patient  general  condition,  comorbidities,  microbi-
logy,  and  complications.  We  found  a  significant  statistical
ssociation  (Fig.  1) between  the  risk  of  dying  and  the
ondition  of  several  of  these  patients,  comorbidities,  micro-
iology,  or  complications.  Patients  older  than  75  years  old;
iving  in  senior  housing;  with  chronic  renal  disease,  lung
ancer,  metastatic  disease,  mobility  impairment,  cachexia,
ementia,  cerebrovascular  disease  (CVD),  or  ischemic  heart
isease  (IHD)  are  at  greater  risk  of  dying  from  pneumonia.
onversely,  gender,  obesity,  tobacco  consumption,  diabetes,
nd  COPD  were  not  associated  with  an  increased  risk  of  dying
or  pneumonia  patients  admitted  to  hospital.  The  MRSA,
seudomonas,  aspiration  pneumonia,  shock,  sepsis,  hospital
eadmissions,  and  one  day  or  even  less  of  hospitalization  are,
n  the  contrary,  significantly  associated  with  an  increased
isk  of  dying  from  pneumonia.  It  is  noteworthy  that  the  iden-
ification  of  a  Pneumococcus  is  associated  with  a  lower  risk
f  dying  from  pneumonia  (Fig.  1).
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Table  2  Pneumonia  Hospital  Mortality,  Adjusted  Risk  Factors  (no cases  -  35,470).
Characteristic  Odds  ratio  P  IC  (95%)
Gender  (M-1/F-2)  0.79  0.00  0.73--0.83
Age ≥  75/<  75  2.69  0.00  2.52--2.87
Metastatic D  4.15  0.00  3.49--4.93
Mobility Impairment  1.83  0.00  1.67--2.01
Cachexia 3.69  0.00  3.00--4.51
Dementia 1.43  0.00  1.32--1.55
Senior Housing 1.70  0.00  1-47--1.05
Tobacco 0.55  0.00  0.44--0.68
Sepsis 2.65  0.00  2.44--2.89
Shock 2.68  0.00  2.25--3.18
Obesity 0.46  0.00  0.36--0.58
COPD 0.69  0.00  0.63--0.75
Asthma 0.34  0.00  0.25-0.45
Chronic Renal  D 1.20  0.00  1.11--1.29
Diabetes 0.84  0.00  0.78--0.90
Cerebrovascular  D 1.31  0.00  1.19--1.44
Ischemic Heart  D 1.28  0.00  1.14--1.43
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After  adjusting  for  the  risk  of  death  from  the  patients’
characteristics,  we  identified  that  individuals  in  the  age
group  over,  or  equal  to  75  years  old,  who  were  living  in  senior
housing,  or  had  previous  cerebrovascular  disease,  cardiac  or
renal  chronic  disease,  dementia,  cachexia,  mobility  impair,
neoplastic  metastatic  disease,  or  upfront  sepsis  were  sig-
nificantly  associated  with  an  increased  risk  of  dying  from
pneumonia  in  the  hospital  (see  Table  2).
Using  these  estimates  it  was  possible  to  compute  a  pre-
dictive  model  for  patients  with  pneumonia  which  required
hospital  admission,  quantifying  their  individual  risk  of  dying,
from  this  disease  (Fig.  2).
Discussion
The  main  findings  of  this  study  led  us  to  understand  that  an
overwhelming  majority  of  patients  dying  from  pneumonia
had  one  or  more  severe  chronic  diseases,  which  certainly
contributed  to  the  outcome.  According  to  a  recent  publi-
cation  of  health  data  in  the  OECD,  the  life  expectancy  at
age  65  in  Portugal  is  17  years  for  males  and  23  for  females.2
However,  more  than  half  of  that  time  is  spent  struggling  with
some  sort  of  disease.2 Despite  treatment  conditions  and  full
access  to  health  services  by  the  Portuguese  population,  we
verified,  year  after  year,  an  increase  in  mortality  due  to
pneumonia  in  Portugal.2 We  are  absolutely  convinced  that
this  entire  chronic  disease  burden  could  affect  the  pneu-
monia  figures,  not  only  in  incidence  but  also  in  mortality.
This  study’s  main  motivation  was  to  look  for  explanations
of  such  a  situation  and  try  to  prepare  future  strategies  to
minimize  the  impact  of  this  disease  on  mortality.  Portu-
gal  has  a  centralized  system  of  registration  for  all  hospital
admissions  involving  all  NHS  hospitals.  Beyond  the  admin-
istrative  data,  we  have  access  to  fully  anonymized  clinical
data.  Usually,  these  data  are  not  patient-driven;  only  admis-
sion  episodes  are  available  for  analysis.  However,  generating
a  code  number  from  the  real  patient  identification  was  pos-
s
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0.00  1.09--1.28
ible,  maintaining  total  patient  anonymization  and  allowing
s  to  identify  the  readmissions  and,  therefore,  to  study
atients  instead  of  admissions.
This  study  has  several  limitations.  This  is  a  retro-
pective  database  analysis,  so  there  is  the  possibility  of
nformation  bias  and  misclassification.  Adjustments  were
ade  for  demographics,  clinic  and  microbiologic  variables.
owever,  some  important  patient  characteristics  (pneu-
onia  severity  PSI  or  CURB65  classification,  mechanical
entilation-vasopressors;  vaccinations;  empiric  antibiotics;
uitability  of  antibiotic  choice  with  bacterial  isolates;  co-
nfections;  specimen  isolates  and  bacteremia),  could  not  be
nalyzed  because  they  were  not  present  in  NHS  database.
espite  all  these  limitations,  this  study  evaluates  a  large
umber  of  patients,  representing  all  the  NHS  patients  from
n  entire  country,  hospitalized  for  severe  pneumonia,  over
he  course  of  one  year.
We  studied  36,366  patients  which  corresponded  to  40,696
ospital  admissions  in  2015.  The  main  targets  of  this  study
ere  patient  characteristics,  particularly  comorbidities  and
heir  influence  on  the  outcome.  The  great  majority  of  the
atients  with  severe  pneumonia  were  elderly,  in  total  30,565
84.1%)  (see  Table  1),  and  had  at  least  one  chronic  long-
tanding  disease.  Similar  to  other  studies,10,11 the  elderly
ere  more  susceptible  to  getting  sick  with  pneumonia  and
eing  hospitalized.
Most  of  the  pneumonias  occurred  during  winter;  how-
ver,  the  deadliest  happened  from  July  to  September.  Host
actors  have  been  increasingly  considered  as  decisive  for
he  outcome  of  the  patients  with  severe  pneumonia.11,12
n  our  study,  advanced  age,  dementia,  mobility  impair-
ent,  metastatic  cancer,  and  living  in  senior  housing  were
ome  of  the  more  important  prehospitalization  conditions
nd  comorbidities  of  the  patients  hospitalized  in  2015  with
evere  pneumonia  in  Portugal.  As  in  other  studies,13--17 these
atients’  characteristics  have  been  shown  to  be  a  deter-
inant  for  the  increased  risk  of  dying  from  pneumonia.
neumonia  after  viral  infections18 is  a  common  occurrence,
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Fig.  2  Hospital  pneum
his  is  explained,  although  not  completely  understood,  by
ssociation  with  the  host  biological  factors,19 disruption  of
he  mucosal  barrier,  and  ciliary  malfunction  caused  by  a
revious  viral  infection  impairing  the  viral  or  bacterial  clear-
nce,  facilitating  bacterial  colonization  and,  subsequently,
he  pneumonia.18,19
We  identified  bacterial  isolates  in  3220  (8.9%)  of  our
atients.  The  distribution  of  the  microbiological  isolates
y  age  groups  had  shown  that  among  the  patients  hos-
italized  for  pneumonia,  the  frequency  of  pneumococcus
ecreased  sharply  with  age;  younger  patients  had  more
requent  pneumococcus  isolates  than  older  patients.  This
bservation  could  explain  the  apparent  ‘‘protective  effect’’
f  the  association  between  pneumonia  with  pneumococcus
dentification  and  the  lower  risk  of  death.
A  plausible  explanation  of  this  observation  could  be  that
neumococcal  pneumonia  is  in  our  series  more  frequent  in
ounger  patients  and,  therefore,  less  likely  to  have  major
omorbidities  that  can  increase  the  risk  of  dying.  The  dis-
ribution  of  bacterial  isolates  throughout  the  year  shows
hat  during  summer,  there  is  proportionally,  more  frequent
dentification  of  gram-negatives  and  staphylococcus  than  in
ther  months.  This  situation  can  be  related  to  the  excess
ortality  observed  during  those  months.  Regardless  of  the
ype,  severe  pneumonia  determining  hospitalization,  the
isk  of  dying  seems  to  be  more  related  to  the  comorbidi-
ies  than  with  the  etiology.  On  the  contrary,  probably  the
eneral  condition  of  the  patients  and  their  susceptibilities
lso  deeply  influence  the  microbial  agent.  Diabetes,  COPD,
besity,  and  tobacco  smoking  are  usually  related  to  pneu-
onia  and  the  risk  of  hospitalization.20,21 However,  in  our
tudy,  they  are  negatively  associated  with  the  risk  of  dying
rom  pneumonia.
Chronic  renal  failure  and  ischemic  heart  disease  are  two
mportant  risk  factors  of  pneumonia  death.  We  observed
rom  our  data  the  association  of  the  risk  of  death  and  the
ength  of  hospital  stay.  The  risk  of  death  for  pneumonia  was
igher  for  short  stays,  decreasing  afterward.  This  observa-
ion  led  us  to  consider  that  a  significant  number  of  patients
T
A
e
 mortality:  risk  model.
ight  have  been  diagnosed  and  started  the  treatment  later
n  the  course  of  the  disease.  If  we  examine  the  age  and
he  comorbidities  of  most  of  the  patients  and  the  possibility
f  many  of  them  living  alone,  the  latter  hypothesis  can  be
onvincing.
onclusion
egardless  of  the  importance  of  the  etiology  and  the  treat-
ent,  the  characteristics  of  the  host  might  be  key  to
xplaining  the  high  mortality  due  to  pneumonia  we  found  in
ur  data.  Elderly  patients  and  the  high  proportion  of  major
omorbidities  such  as  dementia,  cachexia,  severe  mobil-
ty  impairment,  metastatic  cancer,  chronic  renal  disease,
schemic  heart  disease,  cerebrovascular  disease,  sepsis  on
ospital  admission  and  senior  house  living,  are  independent
isk  factors  of  dying  from  pneumonia  in  a  hospital
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